PT-141 (Bremelanotide) is a peptide that interacts with melanocortin receptors in the central nervous system, which are involved in the regulation of sexual arousal and desire. Unlike hormone-based therapies, PT-141 works through neurological pathways rather than directly influencing hormone levels. It has been studied in both men and women in the context of sexual function.